Log in
The Methamphetamine Drug Test Card uses a lateral flow chromatographic immunoassay to detect Methamphetamine in human urine. Simply dip the absorbent end of the test card into the urine specimen for the recommended time, then place it on a flat surface while the reaction develops. Results are typically available within 5 minutes.
This test provides a preliminary analytical result only. Any preliminary positive result should be confirmed using a laboratory confirmation method such as Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Mass Spectrometry (LC-MS/MS).
25 × Individually sealed Methamphetamine (mAMP) Drug Test Cards
Instructions for Use (IFU)
1,000 ng/mL (Urine)
Methamphetamine (mAMP) is a powerful synthetic stimulant that affects the central nervous system (CNS). It increases the release of dopamine in the brain, producing feelings of increased energy, alertness, focus, and euphoria. While methamphetamine has limited medical uses under strict medical supervision, it is more commonly associated with illicit drug use because of its high potential for abuse and addiction.
This test is designed for the qualitative detection of Methamphetamine (mAMP) in human urine at a 1,000 ng/mL screening cutoff, providing a rapid preliminary result for drug screening programs.
Although methamphetamine is widely known as an illicit stimulant, it does have limited medical applications. In the United States, prescription methamphetamine is FDA-approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and, in certain cases, for the short-term treatment of obesity when other therapies have not been effective.
As a central nervous system stimulant, methamphetamine may help improve attention, concentration, and alertness in carefully selected patients. However, because of its significant risk of dependence and misuse, it is prescribed only in limited situations and under close medical supervision.
Methamphetamine is one of the most commonly abused stimulant drugs because it can produce intense feelings of euphoria, increased confidence, heightened alertness, and greater physical energy. These effects also make the drug highly addictive, with repeated use often leading to tolerance, dependence, and substance use disorder.
Long-term methamphetamine misuse has been associated with numerous health complications, including:
Increased energy and alertness
Euphoria
Reduced appetite
Rapid heartbeat
Elevated blood pressure
Anxiety and irritability
Restlessness
Insomnia
Strong drug cravings
Meth, Crystal Meth, Ice, Glass, Tina, Crank, Speed.
Methamphetamine is typically detectable in urine for 2–5 days after use. Heavy or frequent use may extend the detection window depending on metabolism, dosage, frequency of use, and overall health.
The Methamphetamine (mAMP) Drug Test Card provides a fast, accurate, and convenient solution for screening Methamphetamine in human urine. Featuring a 1,000 ng/mL screening cutoff, a simple dip-and-read procedure, and results available in approximately 5 minutes, it is an ideal choice for professional point-of-care testing and home use. Each test card is individually packaged for single-use convenience and delivers reliable preliminary screening results without the need for specialized equipment. As with all rapid immunoassay drug tests, any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Mass Spectrometry (LC-MS/MS) before clinical, legal, or employment decisions are made.
The Methamphetamine (mAMP) Drug Test Card is a rapid, one-step urine drug screening test designed for the qualitative detection of Methamphetamine (mAMP) in human urine. Using a lateral flow chromatographic immunoassay with highly specific monoclonal antibodies, the test provides reliable preliminary screening results at a 1,000 ng/mL cutoff concentration without requiring specialized laboratory equipment.
This easy-to-use dip-and-read test delivers accurate preliminary results in approximately 5 minutes, making it suitable for workplace drug testing, healthcare facilities, rehabilitation centers, law enforcement agencies, educational institutions, and home testing.
Each box contains 25 individually packaged test cards for convenient single-use urine drug screening.
Drug
Typical Detection Window
Methamphetamine (mAMP)
2–5 Days
Drug
Cutoff Level
Methamphetamine (mAMP)
1,000 ng/mL
Two colored lines appear—one in the Control (C) region and one in the Test (T) region. Even a faint line in the Test (T) region should be interpreted as a negative result.
Only one colored line appears in the Control (C) region, while no line appears in the Test (T) region. This indicates that Methamphetamine may be present at or above the 1000 ng/mL screening cutoff. Any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Mass Spectrometry (LC-MS/MS).
If no colored line appears in the Control (C) region, the test is invalid, regardless of whether a Test line appears. Repeat the test using a new test card.

Methamphetamine (mAMP) Drug Test Card 1000 ng/mL | Abbott DMA-114 25/Box
Sign up for updates from leading retailers